Answers are grounded in this paper and cite their sources.
A case report demonstrates effective cyst regression using lower-concentration ethanol in a dog, indicating a viable alternative in clinical settings.
A 10-year-old female Pomeranian was referred after a hepatic cyst was incidentally identified during a routine health check. Ultrasound-guided simple drainage was initially performed, and cytological examination of the aspirated fluid confirmed a simple cyst. However, the cyst re-expanded to its original size within 2 weeks. Therefore, ultrasound-guided percutaneous sclerotherapy was elected using lower-concentration ethanol (83%), a readily available medical disinfectant, rather than conventional high-concentration ethanol. Approximately 50% of the aspirated volume was replaced with 83% ethanol and retained for 20 min to achieve effective epithelial ablation. Post-procedural follow-up revealed a transient increase in cyst size and serum alanine aminotransferase levels on day 3, attributed to the inflammatory sclerosing process; however, these changes resolved spontaneously by day 20. Complete cyst regression was confirmed by day 60, with no recurrence during the 1-year follow-up. This case suggests that lower-concentration ethanol (83%) is a feasible, safe, and effective sclerosing agent for canine hepatic cysts and may represent a practical option in clinical settings where high-concentration ethanol is unavailable.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: